MEDICAL DEVICES REIMBURSEMENT MARKET ANALYSIS

Leading Companies

Global Medical Devices Reimbursement Market: Key Developments

In November 2022, RQM+ announced the launch of reimbursement division. RQM+ now provides comprehensive reimbursement services in addition to regulatory, quality, clinical and laboratory services – supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

In May 2022, the French National Authority for Health provided certain recommendations for adding reimbursement on medical devices such as diagnostic imaging devices, cardiovascular and peripheral vascular devices, and interventional radiology devices.

In April 2021, Aditya Birla Health Insurance Company Ltd. launched a multi-platform campaign ‘#ABHIKaro’. The campaign promotes the idea of ‘Chuno Insurance Jo De Zyada’ (choose an insurance that gives so much more!) to prod the viewers to choose an insurance cover that goes beyond satisfying the bare minimum needs.

Global Medical Devices Reimbursement Market: Key Companies Insights

The global medical devices reimbursement market is highly competitive. This is attributed to the increasing prevalence of chronic diseases and increasing demand for medical devices, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global medical devices reimbursement market are BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others.